Checkpoint Capital L.P. PTGX Holdings History
Checkpoint Capital L.P.'s Protagonist Therapeutics Inc Holding Summary
As of 2025-03-31, Checkpoint Capital L.P. held 175,184.00 shares of Protagonist Therapeutics Inc(PTGX), totaling $8.47 Mil. This investment constitutes 4.65% of their stock portfolio, and Checkpoint Capital L.P. now holds 0.28% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.
The initial trade took place in 2023Q4. And since then Checkpoint Capital L.P. has made 3 purchases of PTGX, at an average price of $27.47, for a total of 530,184.00 shares. In addition, there have been 2 sales at an average price of $42.56 for 355,000.00 shares. Based on historical transaction data and PTGX's current price of $50.48, Checkpoint Capital L.P.'s estimated gain on his PTGX holdings is $9.39 Mil, reflecting a 64.45% gain to date.
Checkpoint Capital L.P. PTGX ($50.48) Holding Chart
Checkpoint Capital L.P. PTGX ($50.48) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
